Works matching IS 13479032 AND DT 2022 AND VI 113 AND IP 2

Results: 39

Recurrent PTPRZ1‐MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 796, doi. 10.1111/cas.15211

By:

Chai, Rui‐Chao;
Liu, Xing;
Pang, Bo;
Liu, Yu‐Qing;
Li, Jing‐Jun;
Li, Yang‐Fang;
Zhao, Zheng;
Du, Jiang;
Bao, Zhao Shi;
Jiang, Tao

Publication type:

Article

TCOF1 coordinates oncogenic activation and rRNA production and promotes tumorigenesis in HCC.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 553, doi. 10.1111/cas.15242

By:

Wu, Chaoshen;
Xia, Dian;
Wang, Dian;
Wang, Shu;
Sun, Zhaoran;
Xu, Bihuai;
Zhang, Daoyong

Publication type:

Article

Biomolecular condensates in cancer biology.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 382, doi. 10.1111/cas.15232

By:

Suzuki, Hiroshi I.;
Onimaru, Koh

Publication type:

Article

High‐throughput and multi‐phases identification of autoantibodies in diagnosing early‐stage breast cancer and subtypes.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 770, doi. 10.1111/cas.15227

By:

Luo, Rongrong;
Zheng, Cuiling;
Song, Wenya;
Tan, Qiaoyun;
Shi, Yuankai;
Han, Xiaohong

Publication type:

Article

E239K mutation abolishes the suppressive effects of lysine‐specific demethylase 1 on migration and invasion of MCF7 cells.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 489, doi. 10.1111/cas.15220

By:

Zhang, Yu;
Wu, Tong;
Zhao, Bo;
Liu, Ziyu;
Qian, Rui;
Zhang, Jing;
Shi, Yueru;
Wan, Youzhong;
Li, Zhe;
Hu, Xin

Publication type:

Article

RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 529, doi. 10.1111/cas.15239

By:

Masuda, Tatsuya;
Maeda, Shintaro;
Shimada, Sae;
Sakuramoto, Naoya;
Morita, Ken;
Koyama, Asami;
Suzuki, Kensho;
Mitsuda, Yoshihide;
Matsuo, Hidemasa;
Kubota, Hirohito;
Kato, Itaru;
Tanaka, Kuniaki;
Takita, Junko;
Hirata, Masahiro;
Kataoka, Tatsuki R;
Nakahata, Tatsutoshi;
Adachi, Souichi;
Hirai, Hideyo;
Mizuta, Shuichi;
Naka, Kazuhito

Publication type:

Article

Hypoxia‐inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 540, doi. 10.1111/cas.15240

By:

Ho, Kuo‐Hao;
Shih, Chwen‐Ming;
Liu, Ann‐Jeng;
Chen, Ku‐Chung

Publication type:

Article

hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR‐139‐3p/CCL5 axis.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 634, doi. 10.1111/cas.15238

By:

Cao, Pei;
Ma, Bo;
Sun, Ding;
Zhang, Weigang;
Qiu, Junyi;
Qin, Lei;
Xue, Xiaofeng

Publication type:

Article

Thrombospondin‐1 induced programmed death‐ligand 1‐mediated immunosuppression by activating the STAT3 pathway in osteosarcoma.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 432, doi. 10.1111/cas.15237

By:

Liu, Zhuochao;
Wen, Junxiang;
Hu, Fangqiong;
Wang, Jun;
Hu, Chuanzhen;
Zhang, Weibin

Publication type:

Article

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 756, doi. 10.1111/cas.15236

By:

Di, Wang;
Fan, Wenhua;
Wu, Fan;
Shi, Zhongfang;
Wang, Zhiliang;
Yu, Mingchen;
Zhai, You;
Chang, Yuanhao;
Pan, Changqing;
Li, Guanzhang;
Kahlert, Ulf Dietrich;
Zhang, Wei

Publication type:

Article

FZD10‐targeted α‐radioimmunotherapy with <sup>225</sup>Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 721, doi. 10.1111/cas.15235

By:

Sudo, Hitomi;
Tsuji, Atsushi B.;
Sugyo, Aya;
Harada, Yosuke;
Nagayama, Satoshi;
Katagiri, Toyomasa;
Nakamura, Yusuke;
Higashi, Tatsuya

Publication type:

Article

Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomas.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 517, doi. 10.1111/cas.15233

By:

Wu, Wei;
Wang, Yichang;
Niu, Chen;
Wahafu, Alafate;
Huo, Longwei;
Guo, Xiaoye;
Xiang, Jianyang;
Li, Xiaodong;
Xie, Wanfu;
Bai, Xiaobin;
Wang, Maode;
Wang, Jia

Publication type:

Article

Cyclin‐dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 802, doi. 10.1111/cas.15234

By:

Kitamura, Shinya;
Yanagi, Teruki;
Maeda, Takuya;
Ujiie, Hideyuki

Publication type:

Article

Glycosylation of MUC6 by α1,4‐linked N‐acetylglucosamine enhances suppression of pancreatic cancer malignancy.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 576, doi. 10.1111/cas.15209

By:

Yuki, Atsuko;
Fujii, Chifumi;
Yamanoi, Kazuhiro;
Matoba, Hisanori;
Harumiya, Satoru;
Kawakubo, Masatomo;
Nakayama, Jun

Publication type:

Article

Aberrant RNA splicing and therapeutic opportunities in cancers.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 373, doi. 10.1111/cas.15213

By:

Yamauchi, Hirofumi;
Nishimura, Kazuki;
Yoshimi, Akihide

Publication type:

Article

Paclitaxel‐based supramolecular hydrogel loaded with mifepristone for the inhibition of breast cancer metastasis.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 733, doi. 10.1111/cas.15230

By:

Zhao, Cui‐Cui;
Zhang, Chuan‐Gui;
Sun, Xuan;
Guo, Qingxiang;
Liu, Jinjian;
Liu, Yan;
Hao, Ya‐Nan;
Feng, Guowei;
Yang, Lijun;
Liu, Hong;
Liu, Jianfeng

Publication type:

Article

LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 709, doi. 10.1111/cas.15229

By:

Liu, Yingqiang;
Lai, Mengzhen;
Li, Shan;
Wang, Yanan;
Feng, Fang;
Zhang, Tao;
Tong, Linjiang;
Zhang, Mengge;
Chen, Hao;
Chen, Yi;
Song, Peiran;
Li, Yan;
Bai, Gang;
Ning, Yi;
Tang, Haotian;
Fang, Yan;
Lu, Xiaoyun;
Geng, Meiyu;
Ding, Ke;
Yu, Ker

Publication type:

Article

Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell‐derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 609, doi. 10.1111/cas.15225

By:

Sasabe, Eri;
Tomomura, Ayumi;
Liu, Hangyu;
Sento, Shinya;
Kitamura, Naoya;
Yamamoto, Tetsuya

Publication type:

Article

Decreased expression of T‐cell‐associated immune markers predicts poor prognosis in patients with follicular lymphoma.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 660, doi. 10.1111/cas.15224

By:

Rai, Shinya;
Inoue, Hiroaki;
Sakai, Kazuko;
Hanamoto, Hitoshi;
Matsuda, Mitsuhiro;
Maeda, Yasuhiro;
Haeno, Takahiro;
Watatani, Yosaku;
Kumode, Takahiro;
Serizawa, Kentaro;
Taniguchi, Yasuhiro;
Hirase, Chikara;
Espinoza, J. Luis;
Morita, Yasuyoshi;
Tanaka, Hirokazu;
Ashida, Takashi;
Tatsumi, Yoichi;
Nishio, Kazuto;
Matsumura, Itaru

Publication type:

Article

SUMOylation regulates Rb hyperphosphorylation and inactivation in uveal melanoma.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 622, doi. 10.1111/cas.15223

By:

Meng, Fengxi;
Yuan, Yiqun;
Ren, Hui;
Yue, Han;
Xu, Binbin;
Qian, Jiang

Publication type:

Article

Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 697, doi. 10.1111/cas.15221

By:

Nakano, Tomoyuki;
Fujimoto, Kenji;
Tomiyama, Arata;
Takahashi, Masamichi;
Achiha, Takamune;
Arita, Hideyuki;
Kawauchi, Daisuke;
Yasukawa, Mami;
Masutomi, Kenkichi;
Kondo, Akihide;
Narita, Yoshitaka;
Maehara, Taketoshi;
Ichimura, Koichi

Publication type:

Article

Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 648, doi. 10.1111/cas.15222

By:

Gao, Shugeng;
Guo, Wei;
Liu, Tiejun;
Liang, Naixin;
Ma, Qianli;
Gao, Yibo;
Tan, Fengwei;
Xue, Qi;
He, Jie

Publication type:

Article

Mechanism of sensitivity to cisplatin, docetaxel, and 5‐fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 478, doi. 10.1111/cas.15218

By:

Zhao, Tong‐Chao;
Zhou, Zhi‐Hang;
Ju, Wu‐Tong;
Liang, Si‐Yuan;
Tang, Xiao;
Zhu, Dong‐Wang;
Zhang, Zhi‐Yuan;
Zhong, Lai‐Ping

Publication type:

Article

A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody‐antigen system.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 411, doi. 10.1111/cas.15217

By:

Wu, Jinyu;
Wang, Peng;
Han, Zhuo;
Li, Tiandong;
Yi, Chuncheng;
Qiu, Cuipeng;
Yang, Qian;
Sun, Guiying;
Dai, Liping;
Shi, Jianxiang;
Wang, Keyan;
Ye, Hua

Publication type:

Article

Methyltransferase‐like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 446, doi. 10.1111/cas.15212

By:

Liu, Tao;
Wang, Hui;
Fu, Zhibin;
Wang, Zheng;
Wang, Jie;
Gan, Xinxin;
Wang, Anbang;
Wang, Linhui

Publication type:

Article

Cost‐effectiveness of carbon‐ion radiotherapy versus stereotactic body radiotherapy for non‐small‐cell lung cancer.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 674, doi. 10.1111/cas.15216

By:

Okazaki, Shohei;
Shibuya, Kei;
Takura, Tomoyuki;
Miyasaka, Yuhei;
Kawamura, Hidemasa;
Ohno, Tatsuya

Publication type:

Article

Low‐carbohydrate diet and risk of cancer incidence: The Japan Public Health Center‐based prospective study.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 744, doi. 10.1111/cas.15215

By:

Cai, Honglin;
Sobue, Tomotaka;
Kitamura, Tetsuhisa;
Ishihara, Junko;
Nanri, Akiko;
Mizoue, Tetsuya;
Iwasaki, Motoki;
Yamaji, Taiki;
Inoue, Manami;
Tsugane, Shoichiro;
Sawada, Norie

Publication type:

Article

PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 500, doi. 10.1111/cas.15214

By:

Sun, Jinmin;
Xu, Yixin;
Liu, Jia;
Cui, Huiyue;
Cao, Haowei;
Ren, Jing

Publication type:

Article

Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 459, doi. 10.1111/cas.15208

By:

Song, Xueli;
An, Yaping;
Chen, Danfeng;
Zhang, Wanru;
Wu, Xuemei;
Li, Chuqiao;
Wang, Sinan;
Dong, Wenxiao;
Wang, Bangmao;
Liu, Tianyu;
Zhong, Weilong;
Sun, Tao;
Cao, Hailong

Publication type:

Article

Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 597, doi. 10.1111/cas.15210

By:

Takei, Hisashi;
Coelho‐Silva, Juan Luiz;
Tavares Leal, Cristina;
Queiroz Arantes Rocha, Adriana;
Mantello Bianco, Thiago;
Welner, Robert S.;
Mishima, Yuta;
Kobayashi, Ikei S.;
Mullally, Ann;
Lima, Keli;
Machado‐Neto, João Agostinho;
Kobayashi, Susumu S.;
Lobo de Figueiredo‐Pontes, Lorena

Publication type:

Article

Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 784, doi. 10.1111/cas.15207

By:

Taniyama, Daiki;
Sakamoto, Naoya;
Takashima, Tsuyoshi;
Takeda, Masahiko;
Pham, Quoc Thang;
Ukai, Shoichi;
Maruyama, Ryota;
Harada, Kenji;
Babasaki, Takashi;
Sekino, Yohei;
Hayashi, Tetsutaro;
Sentani, Kazuhiro;
Pommier, Yves;
Murai, Junko;
Yasui, Wataru

Publication type:

Article

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 587, doi. 10.1111/cas.15205

By:

Ando, Kiyohiro;
Ohira, Miki;
Takada, Ichiro;
Cázares‐Ordoñez, Verna;
Suenaga, Yusuke;
Nagase, Hiroki;
Kobayashi, Shinichi;
Koshinaga, Tsugumichi;
Kamijo, Takehiko;
Makishima, Makoto;
Wada, Satoshi

Publication type:

Article

Dvl2 facilitates the coordination of NF‐κB and Wnt signaling to promote colitis‐associated colorectal progression.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 565, doi. 10.1111/cas.15206

By:

Tang, Feiyu;
Cao, Fuyang;
Lu, Can;
He, Xiang;
Weng, Liang;
Sun, Lunquan

Publication type:

Article

TAS‐116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T‐cell leukemia.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 684, doi. 10.1111/cas.15204

By:

Ikebe, Emi;
Shimosaki, Shunsuke;
Hasegawa, Hiroo;
Iha, Hidekatsu;
Tsukamoto, Yoshiyuki;
Wang, Yu;
Sasaki, Daisuke;
Imaizumi, Yoshitaka;
Miyazaki, Yasushi;
Yanagihara, Katsunori;
Hamaguchi, Isao;
Morishita, Kazuhiro

Publication type:

Article

The spatial distribution of immune cell subpopulations in hepatocellular carcinoma.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 423, doi. 10.1111/cas.15202

By:

Wang, Peng‐Cheng;
Hu, Zhi‐Qiang;
Zhou, Shao‐Lai;
Yu, Song‐Yang;
Mao, Li;
Su, Sheng;
Li, Jia;
Ren, Ning;
Huang, Xiao‐Wu

Publication type:

Article

PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 399, doi. 10.1111/cas.15198

By:

Okadome, Kazuo;
Baba, Yoshifumi;
Yasuda‐Yoshihara, Noriko;
Nomoto, Daichi;
Yagi, Taisuke;
Toihata, Tasuku;
Ogawa, Katsuhiro;
Sawayama, Hiroshi;
Ishimoto, Takatsugu;
Iwatsuki, Masaaki;
Iwagami, Shiro;
Miyamoto, Yuji;
Yoshida, Naoya;
Watanabe, Masayuki;
Komohara, Yoshihiro;
Baba, Hideo

Publication type:

Article

Current status of photodynamic technology for urothelial cancer.

Published in:

Cancer Science, 2022, v. 113, n. 2, p. 392, doi. 10.1111/cas.15193

By:

Inoue, Keiji;
Fukuhara, Hideo;
Yamamoto, Shinkuro;
Karashima, Takashi;
Kurabayashi, Atsushi;
Furihata, Mutsuo;
Hanazaki, Kazuhiro;
Lai, Hung Wei;
Ogura, Shun‐Ichiro

Publication type:

Article

In this issue: Volume 113, Issue 2, February 2022.

Published in:: Cancer Science, 2022, v. 113, n. 2, p. 371, doi. 10.1111/cas.14946
Publication type:: Article

Issue Information.

Published in:: Cancer Science, 2022, v. 113, n. 2, p. 367, doi. 10.1111/cas.14945
Publication type:: Article